Amvona - Displaying items by tag: The SEC

Menu:

Ligand Pharmaceuticals (NASDAQ: LGND) shares plunge 52%, hit 52 week low

Subscribe to this RSS feed

Amvona publishes critical articles and interviews at the intersection of Faith, Finance and Economics.

Tweets

Mon Dec 17 20:50:31 +0000 2018

RT @LemelsonCapital: $LGND shares plunge 52%, hit 52-week low. @Lemelson has made nearly 1,000 distinct allegations of accounting + securit…

Thu Nov 22 15:33:06 +0000 2018

RT @Lemelson: "Continue steadfastly in prayer, being watchful in it with thanksgiving." Col. 4:2 Will soon be jumping on a plane headed fo…

Wed Nov 21 22:02:48 +0000 2018

RT @LemelsonCapital: $LGND shares plunge 45%, @Lemelson Files Reply Brief in #SEC Matter. Read more here: https://t.co/dLqCxCwHma $LGND $…

Tue Nov 20 18:33:37 +0000 2018

RT @LemelsonCapital: Only 3 days left to register for #Athens2018 Conference on Faith + Finance on how the timeless principles of wise inve…

Thu Nov 15 20:57:25 +0000 2018

RT @LemelsonCapital: Sh. be good report from $GEOS AH today, w/ large order from $DWSN likely received in CQ3. Glad to see mngmt acted on O…

225 Cedar Hill Street Suite #200 Marlborough MA 01752 USA

Feel free to email us. We would be happy to answer any questions you might have.